Author

S. Khaleeq

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:protein structure· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. Upadhyaya· 2 shared M. Bhat· 2 shared P. Reddy· 2 shared R. Varadarajan· 2 shared S. Dutta· 2 shared S. Pandey· 2 shared A. J. McAuley· 1 shared A. Tyagi· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Upadhyaya

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Comparative immunogenicity of bacterially expressed soluble trimers and nanoparticle displayed influenza hemagglutinin stem immunogens

U. Kar, S. Khaleeq, P. Garg, M. Bhat, P. Reddy, V. S. Vignesh, A. Upadhyaya, M. Das, C. Ghadiyaram, S. Pandey, S. Dutta, R. Varadarajan

This study compares the immunogenicity of soluble trimeric influenza stem domain immunogens and nanoparticle-displayed versions, showing similar protection against homologous and heterologous viral challenges.

bioRxiv · Mar 14, 2021Immunology

Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative

S. K. Malladi, U. R. Patel, R. S. Rajmani, R. Singh, S. Pandey, S. Kumar, S. Khaleeq, P. J. v. Vuren, S. S. Riddell, S. Goldie, S. Gayathri, D. Chakraborty, P. Kalita, I. Pramanick, N. Agarwal, , R. Varadarajan

This study designs a thermotolerant trimeric RBD vaccine candidate that elicits strong neutralizing antibodies against multiple SARS-CoV-2 variants in animal models.

bioRxiv · Jan 13, 2021Microbiology